Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis
Clinical trial NCT06475508 · COMPLETED
Trial details
- NCT number
- NCT06475508
- Sponsor
- AO GENERIUM
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2024-01-05
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.